IBDEI042 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4856,0)
 ;;=C4A.61^^22^299^77
 ;;^UTILITY(U,$J,358.3,4856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4856,1,3,0)
 ;;=3^Merkle Cell CA,Right Upper Limb,Incl Shoulder
 ;;^UTILITY(U,$J,358.3,4856,1,4,0)
 ;;=4^C4A.61
 ;;^UTILITY(U,$J,358.3,4856,2)
 ;;=^5001152
 ;;^UTILITY(U,$J,358.3,4857,0)
 ;;=C4A.31^^22^299^70
 ;;^UTILITY(U,$J,358.3,4857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4857,1,3,0)
 ;;=3^Merkle Cell CA,Nose
 ;;^UTILITY(U,$J,358.3,4857,1,4,0)
 ;;=4^C4A.31
 ;;^UTILITY(U,$J,358.3,4857,2)
 ;;=^5001145
 ;;^UTILITY(U,$J,358.3,4858,0)
 ;;=C4A.39^^22^299^72
 ;;^UTILITY(U,$J,358.3,4858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4858,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Face,Other
 ;;^UTILITY(U,$J,358.3,4858,1,4,0)
 ;;=4^C4A.39
 ;;^UTILITY(U,$J,358.3,4858,2)
 ;;=^5001146
 ;;^UTILITY(U,$J,358.3,4859,0)
 ;;=C4A.59^^22^299^73
 ;;^UTILITY(U,$J,358.3,4859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4859,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Trunk,Other
 ;;^UTILITY(U,$J,358.3,4859,1,4,0)
 ;;=4^C4A.59
 ;;^UTILITY(U,$J,358.3,4859,2)
 ;;=^5001150
 ;;^UTILITY(U,$J,358.3,4860,0)
 ;;=C4A.8^^22^299^71
 ;;^UTILITY(U,$J,358.3,4860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4860,1,3,0)
 ;;=3^Merkle Cell CA,Overlapping Sites
 ;;^UTILITY(U,$J,358.3,4860,1,4,0)
 ;;=4^C4A.8
 ;;^UTILITY(U,$J,358.3,4860,2)
 ;;=^5001157
 ;;^UTILITY(U,$J,358.3,4861,0)
 ;;=C4A.9^^22^299^78
 ;;^UTILITY(U,$J,358.3,4861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4861,1,3,0)
 ;;=3^Merkle Cell CA,Unspec
 ;;^UTILITY(U,$J,358.3,4861,1,4,0)
 ;;=4^C4A.9
 ;;^UTILITY(U,$J,358.3,4861,2)
 ;;=^5001158
 ;;^UTILITY(U,$J,358.3,4862,0)
 ;;=C84.09^^22^299^83
 ;;^UTILITY(U,$J,358.3,4862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4862,1,3,0)
 ;;=3^Mycosis Fungoides,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4862,1,4,0)
 ;;=4^C84.09
 ;;^UTILITY(U,$J,358.3,4862,2)
 ;;=^5001630
 ;;^UTILITY(U,$J,358.3,4863,0)
 ;;=C84.03^^22^299^86
 ;;^UTILITY(U,$J,358.3,4863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4863,1,3,0)
 ;;=3^Mycosis Fungoides,Intra-Abdominal Lymph Nodes
 ;;^UTILITY(U,$J,358.3,4863,1,4,0)
 ;;=4^C84.03
 ;;^UTILITY(U,$J,358.3,4863,2)
 ;;=^5001624
 ;;^UTILITY(U,$J,358.3,4864,0)
 ;;=C84.06^^22^299^87
 ;;^UTILITY(U,$J,358.3,4864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4864,1,3,0)
 ;;=3^Mycosis Fungoides,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,4864,1,4,0)
 ;;=4^C84.06
 ;;^UTILITY(U,$J,358.3,4864,2)
 ;;=^5001627
 ;;^UTILITY(U,$J,358.3,4865,0)
 ;;=C84.02^^22^299^88
 ;;^UTILITY(U,$J,358.3,4865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4865,1,3,0)
 ;;=3^Mycosis Fungoides,Intrathoracic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,4865,1,4,0)
 ;;=4^C84.02
 ;;^UTILITY(U,$J,358.3,4865,2)
 ;;=^5001623
 ;;^UTILITY(U,$J,358.3,4866,0)
 ;;=C84.04^^22^299^82
 ;;^UTILITY(U,$J,358.3,4866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4866,1,3,0)
 ;;=3^Mycosis Fungoides,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,4866,1,4,0)
 ;;=4^C84.04
 ;;^UTILITY(U,$J,358.3,4866,2)
 ;;=^5001625
 ;;^UTILITY(U,$J,358.3,4867,0)
 ;;=C84.01^^22^299^84
 ;;^UTILITY(U,$J,358.3,4867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4867,1,3,0)
 ;;=3^Mycosis Fungoides,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,4867,1,4,0)
 ;;=4^C84.01
 ;;^UTILITY(U,$J,358.3,4867,2)
 ;;=^5001622
 ;;^UTILITY(U,$J,358.3,4868,0)
 ;;=C84.05^^22^299^85
 ;;^UTILITY(U,$J,358.3,4868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4868,1,3,0)
 ;;=3^Mycosis Fungoides,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,4868,1,4,0)
 ;;=4^C84.05
 ;;^UTILITY(U,$J,358.3,4868,2)
 ;;=^5001626
 ;;^UTILITY(U,$J,358.3,4869,0)
 ;;=C84.08^^22^299^89
 ;;^UTILITY(U,$J,358.3,4869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4869,1,3,0)
 ;;=3^Mycosis Fungoides,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,4869,1,4,0)
 ;;=4^C84.08
 ;;^UTILITY(U,$J,358.3,4869,2)
 ;;=^5001629
 ;;^UTILITY(U,$J,358.3,4870,0)
 ;;=C84.07^^22^299^90
 ;;^UTILITY(U,$J,358.3,4870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4870,1,3,0)
 ;;=3^Mycosis Fungoides,Spleen
 ;;^UTILITY(U,$J,358.3,4870,1,4,0)
 ;;=4^C84.07
 ;;^UTILITY(U,$J,358.3,4870,2)
 ;;=^5001628
 ;;^UTILITY(U,$J,358.3,4871,0)
 ;;=C84.00^^22^299^91
 ;;^UTILITY(U,$J,358.3,4871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4871,1,3,0)
 ;;=3^Mycosis Fungoides,Unspec Site
 ;;^UTILITY(U,$J,358.3,4871,1,4,0)
 ;;=4^C84.00
 ;;^UTILITY(U,$J,358.3,4871,2)
 ;;=^5001621
 ;;^UTILITY(U,$J,358.3,4872,0)
 ;;=I78.1^^22^300^8
 ;;^UTILITY(U,$J,358.3,4872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4872,1,3,0)
 ;;=3^Nevus,Non-Neoplastic
 ;;^UTILITY(U,$J,358.3,4872,1,4,0)
 ;;=4^I78.1
 ;;^UTILITY(U,$J,358.3,4872,2)
 ;;=^269807
 ;;^UTILITY(U,$J,358.3,4873,0)
 ;;=L60.3^^22^300^2
 ;;^UTILITY(U,$J,358.3,4873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4873,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,4873,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,4873,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,4874,0)
 ;;=L92.1^^22^300^4
 ;;^UTILITY(U,$J,358.3,4874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4874,1,3,0)
 ;;=3^Necrobiosis Lipoidica NEC
 ;;^UTILITY(U,$J,358.3,4874,1,4,0)
 ;;=4^L92.1
 ;;^UTILITY(U,$J,358.3,4874,2)
 ;;=^5009462
 ;;^UTILITY(U,$J,358.3,4875,0)
 ;;=L20.81^^22^300^7
 ;;^UTILITY(U,$J,358.3,4875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4875,1,3,0)
 ;;=3^Neurodermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,4875,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,4875,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,4876,0)
 ;;=D48.5^^22^300^6
 ;;^UTILITY(U,$J,358.3,4876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4876,1,3,0)
 ;;=3^Neoplasm,Skin,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,4876,1,4,0)
 ;;=4^D48.5
 ;;^UTILITY(U,$J,358.3,4876,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,4877,0)
 ;;=D49.2^^22^300^5
 ;;^UTILITY(U,$J,358.3,4877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4877,1,3,0)
 ;;=3^Neoplasm,Bone/Soft Tissue/Skin,Unspec Behavior
 ;;^UTILITY(U,$J,358.3,4877,1,4,0)
 ;;=4^D49.2
 ;;^UTILITY(U,$J,358.3,4877,2)
 ;;=^5002272
 ;;^UTILITY(U,$J,358.3,4878,0)
 ;;=L60.0^^22^300^3
 ;;^UTILITY(U,$J,358.3,4878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4878,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,4878,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,4878,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,4879,0)
 ;;=L60.9^^22^300^1
 ;;^UTILITY(U,$J,358.3,4879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4879,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,4879,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,4879,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,4880,0)
 ;;=Z91.19^^22^300^9
 ;;^UTILITY(U,$J,358.3,4880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4880,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,4880,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,4880,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,4881,0)
 ;;=E80.1^^22^301^21
 ;;^UTILITY(U,$J,358.3,4881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4881,1,3,0)
 ;;=3^Porphyria Cutanea Tarda
 ;;^UTILITY(U,$J,358.3,4881,1,4,0)
 ;;=4^E80.1
 ;;^UTILITY(U,$J,358.3,4881,2)
 ;;=^5002982
 ;;^UTILITY(U,$J,358.3,4882,0)
 ;;=L56.4^^22^301^20
 ;;^UTILITY(U,$J,358.3,4882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4882,1,3,0)
 ;;=3^Polymorphous Light Eruption
 ;;^UTILITY(U,$J,358.3,4882,1,4,0)
 ;;=4^L56.4
 ;;^UTILITY(U,$J,358.3,4882,2)
 ;;=^5009218
 ;;^UTILITY(U,$J,358.3,4883,0)
 ;;=L10.0^^22^301^4
 ;;^UTILITY(U,$J,358.3,4883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4883,1,3,0)
 ;;=3^Pemphigus Vulgaris
 ;;^UTILITY(U,$J,358.3,4883,1,4,0)
 ;;=4^L10.0
 ;;^UTILITY(U,$J,358.3,4883,2)
 ;;=^91129
 ;;^UTILITY(U,$J,358.3,4884,0)
 ;;=L41.3^^22^301^2
 ;;^UTILITY(U,$J,358.3,4884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4884,1,3,0)
 ;;=3^Parapsoriasis,Small Plague
 ;;^UTILITY(U,$J,358.3,4884,1,4,0)
 ;;=4^L41.3
 ;;^UTILITY(U,$J,358.3,4884,2)
 ;;=^5009173
 ;;^UTILITY(U,$J,358.3,4885,0)
 ;;=L41.4^^22^301^1
 ;;^UTILITY(U,$J,358.3,4885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4885,1,3,0)
 ;;=3^Parapsoriasis,Large Plague
 ;;^UTILITY(U,$J,358.3,4885,1,4,0)
 ;;=4^L41.4
 ;;^UTILITY(U,$J,358.3,4885,2)
 ;;=^5009174
 ;;^UTILITY(U,$J,358.3,4886,0)
 ;;=L28.1^^22^301^31
 ;;^UTILITY(U,$J,358.3,4886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4886,1,3,0)
 ;;=3^Prurigo Nodularis
 ;;^UTILITY(U,$J,358.3,4886,1,4,0)
 ;;=4^L28.1
 ;;^UTILITY(U,$J,358.3,4886,2)
 ;;=^5009148
 ;;^UTILITY(U,$J,358.3,4887,0)
 ;;=H61.001^^22^301^6
 ;;^UTILITY(U,$J,358.3,4887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4887,1,3,0)
 ;;=3^Perichondritis Right External Ear,Unspec
 ;;^UTILITY(U,$J,358.3,4887,1,4,0)
 ;;=4^H61.001
 ;;^UTILITY(U,$J,358.3,4887,2)
 ;;=^5006499
 ;;^UTILITY(U,$J,358.3,4888,0)
 ;;=H61.002^^22^301^5
 ;;^UTILITY(U,$J,358.3,4888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4888,1,3,0)
 ;;=3^Perichondritis Left External Ear,Unspec
 ;;^UTILITY(U,$J,358.3,4888,1,4,0)
 ;;=4^H61.002
 ;;^UTILITY(U,$J,358.3,4888,2)
 ;;=^5006500
 ;;^UTILITY(U,$J,358.3,4889,0)
 ;;=L81.0^^22^301^22
 ;;^UTILITY(U,$J,358.3,4889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4889,1,3,0)
 ;;=3^Postinflammatory Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,4889,1,4,0)
 ;;=4^L81.0
 ;;^UTILITY(U,$J,358.3,4889,2)
 ;;=^5009310
 ;;^UTILITY(U,$J,358.3,4890,0)
 ;;=L81.7^^22^301^16
 ;;^UTILITY(U,$J,358.3,4890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4890,1,3,0)
 ;;=3^Pigmented Purpuric Dermatosis
 ;;^UTILITY(U,$J,358.3,4890,1,4,0)
 ;;=4^L81.7
 ;;^UTILITY(U,$J,358.3,4890,2)
 ;;=^5009317
 ;;^UTILITY(U,$J,358.3,4891,0)
 ;;=L29.8^^22^301^33
 ;;^UTILITY(U,$J,358.3,4891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4891,1,3,0)
 ;;=3^Pruritus NEC
 ;;^UTILITY(U,$J,358.3,4891,1,4,0)
 ;;=4^L29.8
 ;;^UTILITY(U,$J,358.3,4891,2)
 ;;=^5009152
 ;;^UTILITY(U,$J,358.3,4892,0)
 ;;=Z85.828^^22^301^10
 ;;^UTILITY(U,$J,358.3,4892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4892,1,3,0)
 ;;=3^Personal Hx of Malig Neop of Skin
